Search

Your search keyword '"Magrans, Jose Oriol"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Magrans, Jose Oriol" Remove constraint Author: "Magrans, Jose Oriol" Topic regulation (ec) no 396/2005 Remove constraint Topic: regulation (ec) no 396/2005
49 results on '"Magrans, Jose Oriol"'

Search Results

1. Review of the existing maximum residue levels for dithiocarbamates according to Article 12 of Regulation (EC) No 396/2005.

2. Review of the existing maximum residue levels for tetraconazole according to Article 12 of Regulation (EC) No 396/2005

3. Review of the existing maximum residue levels for novaluron according to Article 12 of Regulation (EC) No 396/2005

4. Review of the existing maximum residue levels for cypermethrins according to Article 12 of Regulation (EC) No 396/2005.

5. Targeted review of maximum residues levels (MRLs) for haloxyfop‐P.

6. Review of the existing maximum residue levels for pyriproxyfen according to Article 12 of Regulation (EC) No 396/2005.

7. Targeted review of maximum residues levels (MRLs) for indoxacarb.

8. Review of the existing maximum residue levels for isoxaben according to Article 12 of Regulation (EC) No 396/2005.

9. Review of the existing maximum residue levels for spirodiclofen according to Article 12 of Regulation (EC) No 396/2005.

10. Focussed assessment of certain existing maximum residues levels of concern for abamectin.

11. Review of the existing maximum residue levels for metobromuron according to Article 12 of Regulation (EC) No 396/2005 .

12. Review of the existing maximum residue levels for Beta-cyfluthrin and Cyfluthrin according to Article 12 of Regulation (EC) No 396/2005.

13. Review of the existing maximum residue levels for penthiopyrad according to Article 12 of Regulation (EC) No 396/2005 .

14. Review of the existing maximum residue levels for cyflumetofen according to Article 12 of Regulation (EC) No 396/2005.

15. Reasoned opinion on the joint review of maximum residue levels (MRLs) for fosetyl, disodium phosphonate and potassium phosphonates according to Articles 12 and 43 of Regulation (EC) No 396/2005.

16. Reasoned opinion on the toxicological properties and maximum residue levels (MRLs) for the benzimidazole substances carbendazim and thiophanate‐methyl.

17. Review of the existing maximum residue levels for isopyrazam according to Article 12 of Regulation (EC) No 396/2005.

18. Review of the existing maximum residue levels for 8‐hydroxyquinoline according to Article 12 of Regulation (EC) No 396/2005.

19. Review of the existing maximum residue levels for pinoxaden according to Article 12 of Regulation (EC) No 396/2005.

20. Review of the existing maximum residue levels for cyproconazole according to Article 12 of Regulation (EC) No 396/2005.

21. Review of the existing maximum residue levels for thiram according to Article 12 of Regulation (EC) No 396/2005.

22. Review of the existing maximum residue levels for sulfuryl fluoride according to Article 12 of Regulation (EC) No 396/2005.

23. Reasoned opinion on the toxicological properties and maximum residue levels for propoxur.

24. Focussed assessment of certain existing MRLs of concern for methoxyfenozide.

25. Review of the existing maximum residue levels for quinoxyfen according to Article 12 of Regulation (EC) No 396/2005.

26. Review of the existing maximum residue levels for oxyfluorfen according to Article 12 of Regulation (EC) No 396/2005.

27. Review of the existing maximum residue levels for pyroxsulam according to Article 12 of Regulation (EC) No 396/2005.

28. Review of the existing maximum residue levels for Streptomyces lydicus strain WYEC 108 according to Article 12 of Regulation (EC) No 396/2005.

29. Review of the existing maximum residue levels for chlorantraniliprole according to Article 12 of Regulation (EC) No 396/2005.

30. Review of the existing maximum residue levels for Pseudomonas sp. strain DSMZ 13134 according to Article 12 of Regulation (EC) No 396/2005.

31. Review of the existing maximum residue levels for aminopyralid according to Article 12 of Regulation (EC) No 396/2005.

32. Review of the existing maximum residue levels for 6‐benzyladenine according to Article 12 of Regulation (EC) No 396/2005.

33. Review of the existing maximum residue levels for Bacillus pumilus QST 2808 according to Article 12 of Regulation (EC) No 396/2005.

34. Review of the existing maximum residue levels for fluopyram according to Article 12 of Regulation (EC) No 396/2005.

35. Review of the existing maximum residue levels for ipconazole according to Article 12 of Regulation (EC) No 396/2005.

36. Review of the existing maximum residue levels for spirotetramat according to Article 12 of Regulation (EC) No 396/2005.

37. Review of the existing maximum residue levels for bixafen according to Article 12 of Regulation (EC) No 396/2005.

38. Review of the existing maximum residue levels for terbuthylazine according to Article 12 of Regulation (EC) No 396/2005.

39. Review of the existing maximum residue levels for metamitron according to Article 12 of Regulation (EC) No 396/2005.

40. Review of the existing maximum residue levels for diclofop (considered variant diclofop-methyl) according to Article 12 of Regulation (EC) No 396/2005.

41. Review of the existing maximum residue levels for thiencarbazone-methyl according to Article 12 of Regulation (EC) No 396/2005.

42. Review of the existing maximum residue levels for benalaxyl-M according to Article 12 of Regulation (EC) No 396/2005.

43. Review of the existing maximum residue levels for pyridaly laccording to Article 12 of Regulation (EC) No 396/2005.

44. Review of the existing maximum residue levels for hymexazol according to Article 12 of Regulation (EC) No 396/2005.

45. Review of the existing maximum residue levels for penflufen according to Article 12 of Regulation (EC) No 396/2005.

46. Review of the existing maximum residue levels for emamectin according to Article 12 of Regulation (EC) No 396/2005.

47. Review of the existing maximum residue levels for fluopicolide according to Article 12 of Regulation (EC) No 396/2005.

48. Review of the existing maximum residue levels for bupirimate according to Article 12 of Regulation (EC) No 396/2005.

49. Review of the existing maximum residue levels for clethodim according to Article 12 of Regulation (EC) No 396/2005.

Catalog

Books, media, physical & digital resources